Cinacalcet in the treatment of persistent hyperparathyroidism after kidney transplantation

Clinical Nephrology

Volumn 75, Issue 3, 2011, Pages 263-268

  Pinho, L R S ^a   Santos, M J C Ribeiro ^a   Vasconcelos, M Pestana ^a  

^a University of Porto   (Portugal)

Author keywords

Cinacalcet; Hypercalcemia; Hyperparathyroidism; Kidney transplant

Indexed keywords

CINACALCET; CYCLOSPORIN; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARATHYROID HORMONE; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; MALE; PHOSPHATE BLOOD LEVEL;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CALCIMIMETIC AGENTS; CALCIUM; FEMALE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, SECONDARY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NAPHTHALENES; PARATHYROID HORMONE; PHOSPHORUS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79951941014     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP75263     Document Type: Article

References (27)

1. Torres A, Lorenzo V, Salido E. Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol. 2002; 13: 551-558. (Pubitemid 34106300)
2. Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant. 2004; 19: 1281-1287. (Pubitemid 38628152)
3. Torres A, Rodriguez AP, Concépcion MT, Garcia S, Rufino M, Martin B, Perez L, Machado M, de Bonis E, Losada M, Hernandez D, Lorenzo V. Parathyroid function in long-termrenal transplanted patients: Importance of pre-transplant PTH concentrations. Nephrol Dial Transplant. 1998; 13: 94.
4. Setteberg L, Sandberg J, Elinder C-G, Nordenstrom J. Bone demineralization after renal transplantation: Contribution of secondary hyperparathyroidism manifested by hypercalcaemia. Nephrol Dial Transplant. 1996; 11: 1825.
5. Ball AM, Gillen DL, Sherrard D, Weiss NS, Emerson SS, Selinger SL, Kestenbaum BR, Stehman- Breen C. Risk of hip fracture among dialysis and renal transplant patients. JAMA. 2002; 288: 3014-3018. (Pubitemid 35471163)
6. Egbuna OI, Taylor JG, Bushinsky DA, Zand MS. Elevated calcium phosphate product after renal tranplantation is a risk factor for graft failure. Clin Transplant. 2007; 21: 558.
7. Evenepoel P, Claes K, Kuypers D. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single center study. Nephrol Dial Transplant. 2005; 20: 1714.
8. Sterrett JR, Strom J, Stummvoll HK, Bahner U, Disney A, Soroka SD, Corpier C, Arruda JA, Schwanauer LE, Klassen PS, Olson KA, Block GA. Cinacalcet HCl (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism. Clin Nephrol. 2007; 68: 10-17. (Pubitemid 47045487)
9. Malluche HH, Monier-Faugere MC, Wang G, Frazao JM, Charytan C, Coburn JW, Coyne DW, Kaplan MM, Baker N, McCary LC, Turner SA, Goodman WG. An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. Clin Nephrol. 2008; 69: 269-278.
10. Unbehaun R, Lauerwald W. Successful use of cinacalcet HCl in a patient with end stage renal failure and refractory secondary hyperparathyroidism due to parathyromatosis. Clin Nephrol. 2007; 67: 188-192. (Pubitemid 46416380)
11. Regidor A. Cinacalcet reduces vascular and soft tissue calcification in secondary hyperparathyroidism in hemodialysis patients: a case report. Clin Nephrol. 2009; 71: 207-213.
12. Srinivas TR, Schold JD, Womer KL, Kaplan B, Howard RJ, Bucci CM. Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin J Am Soc Nephrol. 2006; 1: 323-326.
13. El-Amm JM, Doshi MD, Singh A, Migdal S, Morawski K, Sternbauer D, Cincotta E, West MS, Losanoff JE, Gruber SA. Preliminary experience with cinacalcet use in persistent secondary hyper-parathyroidism after kidney transplantation. Transplantation. 2007; 83: 546-549. (Pubitemid 46440240)
14. Leca N, Laftavi M, Gundroo A, Kohli R, Min I, Karam J, Sridhar N, Blessios G, Venuto R, Pankewycz O. Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet. Am J Transplant. 2006; 6: 2391-2395. (Pubitemid 44359425)
15. Kruse AE, Eisenberger U, Frey FJ, Mohaupt MG. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant. 2005; 20: 1311-1314. (Pubitemid 41435024)
16. Serra AL, Schwartz AA, Wick FH, Marti HP, Wuthrich RP. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant. 2005; 20: 1315-1319. (Pubitemid 41430604)
17. Bergua C, Torregrosa JV, Fuster D, Gutierrez- Dalmau A, Oppenheimer F, Campistol JM. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism. Transplantation. 2008; 86: 423.
18. López V, Toledo R, Sola E, Gutiérrez C, Sujan S, Rodríguez MA, Cabello M, Burgos D, González- Molina M, Hernández D. Treatment with Cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism. Transplant Proc. 2009; 41: 2394-2395.
19. Gomez-Marques G, Obrador-Mulet A, Vilar-Gimeno A, Pascual-Felip MJ, Alarcon-Zurita A, Molina- Guasch M, Uriol-Rivera M, Munar-Vila MA, Losada-Gonzalez P. Treatment with cinacalcet of secondary hyperparathyroidism after renal transplantation. Transplant Proc. 2009; 41: 2139-2143.
20. Apostolou T, Damianou L, Kotsiev V, Drakopoulos S, Hadjiconstantinou V. Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet. Clin Nephrol. 2006; 65: 374-377. (Pubitemid 43676425)
21. National Kidney Foundation. K/DOQI clinical practice guidelines: bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42 (Suppl): 1-201.
22. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med. 1996; 325: 544-550.
23. Hernandez D, Rufino M, Bartolomei S, Gonzalez- Rinne A, Lorenzo V, Cobo M, Torres A. Clinical impact of preexisting vascular calcifications on mortality after renal transplantation. Kidney Int. 2005; 67: 2015.
24. Gwinner W, Suppa S, Mengel M, Hoy L, Kreipe HH, Haller H, Schwarz A. Early Calcification of Renal Allografts Detected by Protocol Biopsies: Causes and Clinical Implications. Am J Transplant. 2005; 5: 1934.
25. Grotz WH, Mundinger A, Gugel B, Exner V, Kirste G, Schollmeyer PJ. Bone fracture and osteodensitometry with dual-energy x-ray absorptiometry in kidney transplant recipients. Transplantation. 2002; 74: 496-500.
26. Carlini RG, Rojas E, Weisinger JR, Lopez M, Martinis R, Arminio A, Bellorin-Font E. Bone disease in patients with long-term renal transplantation and normal renal function. Am J Kidney Dis. 2000; 36: 160-166. (Pubitemid 30432578)
27. Borchhardt K, Sulzbacher I, Benesch T, Fodinger M, Sunder-Plassman G, Haas M. Low-turnover bone disease in hypercalcemic hyperparathyroidism after renal transplantation. Am J Transplantation. 2007; 7: 2515-2521. (Pubitemid 47561599)